New Filings & Updated Terms (Ending 5.31.19am)

NEW FILINGS

Company: Adaptive Biotechnologies Corporation
Symbol: ADPT
Description: They are advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Goldman Sachs & Co., J.P. Morgan, BofA Merrill Lynch
Co-Manager(s): Cowen, Guggenheim, William Blair, BTIG
Filed: 5-30-19
Listed Cash Raise: $230m

Company: Morphic Holding, Inc.
Symbol: MORF
Description: They are a biopharmaceutical company applying our proprietary insights into integrins to discover and develop a pipeline of potentially first-in-class oral small-molecule integrin therapeutics.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Jefferies, Cowen, BMO Capital Markets, Wells Fargo Securities
Filed: 5-30-19
Listed Cash Raise: $86.25m

Company: Genmab A/S
Symbol: GMAB
Description: They are an international biotechnology company specializing in antibody therapeutics for the treatment of cancer and other diseases.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): BofA Merrill Lynch, Morgan Stanley, Jefferies
Co-Manager(s): Guggenheim Securities, RBC Capital
Filed: 5-28-19
Listed Cash Raise: $500m

Company: Linx S.A.
Symbol: LINX
Description: They are a leading cloud-based technology company in Latin America and a market leader in Brazil in terms of revenue.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Goldman Sachs, JP Morgan, Jefferies, BofA Merrill Lynch, Itau BBA
Filed: 5-29-19
Listed Cash Raise: $100m

Company: Cambium Networks, Inc
Symbol: CMBM
Description: They provide wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises and government agencies.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): JP Morgan, Goldman Sachs
Co-Manager(s): Deutsche Bank, Raymond James, JMP Securities, Oppenheimer
Filed: 5-29-19
Listed Cash Raise: $75m

Company: Akero Therapeutics
Symbol: AKRO
Description: They are a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical need.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): JP Morgan, Jefferies, Evercore ISI
Co-Manager(s): Roth Capital
Filed: 5-24-19
Listed Cash Raise: $86.25m

Company: Prevail Therapeutics Inc.
Symbol: PRVL
Description: They are a gene therapy company leveraging breakthroughs in human genetics with the goal of developing and commercializing disease-modifying AAV-based gene therapies for patients with devastating neurodegenerative diseases.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Cowen
Co-Manager(s): Wedbush PacGrow
Filed: 5-24-19
Listed Cash Raise: $100m

Company: Dermavant Sciences, Inc.
Symbol: DRMT
Description: They are a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in medical dermatology.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Jefferies, SVB Leerink, Guggenheim Securities
Filed: 5-24-19
Listed Cash Raise: $100m

Company: BridgeBio Pharma, Inc.
Symbol: BBIO
Description: They are a team of experienced drug discoverers, developers and innovators working to create life-altering medicines that target well-characterized genetic diseases at their source.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): J.P. Morgan, Goldman Sachs & Co, Jefferies, SVB Leerink, KKR
Co-Manager(s): Piper Jaffray, Mizuho Securities, BMO Capital Markets, Raymond James
Filed: 5-24-19
Listed Cash Raise: $225m

Company: Atreca Inc
Symbol: BCEL
Description: They are a biopharmaceutical company utilizing our differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Cowen, Evercore ISI, Stifel
Co-Manager(s): Canaccord Genuity, Brookline Capital
Filed: 5-24-19
Listed Cash Raise: $100m

TERMS ADDED

Company: CrowdStrike Holdings Inc.
Symbol: CRWD
Description: They believe they are defining a new category called the Security Cloud, with the power to transform the security industry much the same way the cloud has transformed the CRM, HR, and service management industries.
Shares: 18 million
Price Range: $19.00-$23.00
Trade Date: Wednesday, 6/12
Underwriter(s): Goldman Sachs, JP Morgan, BofA Merrill Lynch, Barclays
Co-Manager(s): Credit Suisse, Jefferies, RBC Capital, Stifel, HSBC, Macquarie Capital, Piper Jaffray, SunTrust Robinson Humphrey, BTIG, JMP Securities, Mizuho Securities, Needham & Co., Oppenheimer & Co.
Terms Added: 5-28-19

Company: Revolve Group, Inc
Symbol: RVLV
Description: REVOLVE is the next-generation fashion retailer for millennial consumers.
Shares: 11.8 million
Price Range: $16.00-$18.00
Trade Date: Friday, 6/7
Underwriter(s): Morgan Stanley, Credit Suisse, BofA Merrill Lynch, Barclays, Jefferies
Co-Manager(s): Cowen, Guggenheim Securities, Raymond James, William Blair
Terms Added: 5-27-19

Company: GSX Techedu Inc.
Symbol: GSX
Description: They are a technology-driven education company.
Shares: 19.8 million
Price Range: $9.50-$11.50
Trade Date: Thursday, 6/6
Underwriter(s): Credit Suisse, Deutsche Bank
Co-Manager(s): Barclays, CLSA
Terms Added: 5-24-19

Company: Mohawk Group Holdings
Symbol: MWK
Description: Mohawk is a rapidly growing technology-enabled consumer products company.
Shares: 3.33 million
Price Range: $14.00-$16.00
Trade Date: Week of 6/10
Underwriter(s): Roth Capital, AGP
Co-Manager(s): National Securities
Terms Added: 5-24-19